gilead forecast 2021 growth strong remdesivir covid19 sale
reuter  gilead scienc inc  thursdai forecast  2021 result  wall street estim  post  26 rise  fourthquarter 2020 revenu driven  sale   antivir drug remdesivir   us  treat covid19 patient
